GlenPost
Dean Porter

Dean Porter

Dean Porter writes about the slower currents beneath daily ticker swings, focusing on dividend growth, buyback trends, and how patient capital behaves during uncertain cycles. He favors long-form explanations, walking readers through balance sheets and cash flow statements rather than headline numbers. Curious about industrial and utility names most others overlook, he treats every article as a chance to teach fundamentals rather than chase the news cycle.

45 articles

Medicare to Cover GLP1 Drugs at $50
Markets

Medicare to Cover GLP1 Drugs at $50

Medicare will soon cover Wegovy and Zepbound for weight loss at $50 a month under a new pilot program. Here's who qualifies and how much it could save you.